Skip to main content

stock

BTCY · BIOTRICITY INC.

What BIOTRICITY INC. reports to the SEC, read from its filings.

Open in the app

Price

The live BTCY price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on BTCY.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
19,914,003 as of 2026-08-19 (XBRL frame CY2026Q3I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
81.5%
Operating
9.6%
Net
-16.4%

Returns

ROE
—
ROA
-44.7%

Health

Current ratio
0.1x
Debt/equity
—

Deep value

NCAV
-$34.12M
NCAV per share
-$1.71
Price/NCAV
Locked
NNWC
-$36.74M
NNWC per share
-$1.84
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$4.28M$3.53M$158,068-$959,468
10-Q filed 2026-08-19
2026-03-31$4.25M$3.40M$694,557-$324,182
10-K filed 2026-07-14
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-12-31$3.99M$3.25M$440,915-$717,067
10-Q filed 2026-02-11
2025-09-30$3.89M$3.18M$273,819-$690,913
10-Q filed 2025-11-14
2025-06-30$3.87M$3.12M$281,945-$671,977
10-Q filed 2026-08-19
2025-03-31$3.70M$2.98M-$855,466-$1.94M
10-K filed 2026-07-14
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-12-31$3.62M$2.76M-$168,982-$1.23M
10-Q filed 2026-02-11
2024-09-30$3.27M$2.46M-$307,672-$1.56M
10-Q filed 2025-11-14
Assets
$6.02M
Equity
-$35.41M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2026-03-31$16.00M$1.69M-$2.40M—
2025-03-31$13.79M-$2.45M-$8.42M—
2024-03-31$12.06M-$8.83M-$14.09M—
2023-03-31$9.64M-$15.41M-$18.66M—
2022-03-31$7.65M-$16.74M-$29.13M-$15.19M
2021-03-31$3.38M—-$15.49M—
2020-03-31$1.42M—-$11.07M—
2019-03-31$398,200—-$8.59M—
2018-03-31——-$8.62M—
2017-03-31——-$7.81M—

Company filings

events

  • Executive or director change

    Executive or director change
    Sep 258-K
  • Material agreement, Unregistered share sale, Bylaws or fiscal year change

    Material agreementUnregistered share saleBylaws or fiscal year change
    May 18-K
  • Results

    Results
    Feb 188-K
  • Results

    Results
    11/18/20258-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named BTCY, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about BTCY.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about BTCY.

nakagai

Signals on BTCY come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the BTCY board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

BIOTRICITY INC. (BTCY): SEC filings, financials and insider trades · Nakagai